Skip to main content

Table 1 Comparison of dedicated heart failure registries

From: Blood pressure and heart failure

 KorAHF [36]KorHF [37]ASIAN-HF [38]ATTEND [39]ADHERE [40, 41]ESC-HF-LT [42]
 2011–20142004–20092012–20152007–20112002–20042011–2013
N5625320052764837159,1684449
Age, years (SD)68.5 (14.5)67.6 (14.3)59.6 (13.1)73.0 (13.8)72.4 (14.1)69.4 (13.0)
Male, %53.255.978.257.948.462.6
BMI, kg/m223.3 (3.9)23.2 (4.0)24.9 (5.1)  28.7 (5.4)
NYHA class III-IV, %84.874.03581.47685.2
SBP, mmHg131.2 (30.3)130.5 (3.2)118.4 (20.2)145.5 (36.7)143.9 (33.2)133.5 (28.2)
DBP, mmHg78.6 (18.8)77.9 (18.0)72.4 (12.6)82.6 (22.6)77.7 (20.2) 
HR, beats/minute92.6 (26.0)91.2 (25.4)79.7 (16.2)98.6 (29.1) 90.8 (25.3)
EF, %37.7 ± 15.638.5 ± 15.728 [22, 33]53.4% with
EF <40%
37.8 ± 17.339.0 [30, 43]
Etiology (%)
 - Hypertension4.036.7 18Up to 30%
in EF ≥ 55%
8.2
 - Ischemic heart disease37.652.347.031.1 56.5
Medical history (%)
 - Hypertension62.246.551.969.373.965.6
 - Ischemic heart disease42.9 50.2 57.553.8
 - Diabetes mellitus40.030.540.436.24439.0
 - Atrial fibrillation / atrial flutter28.520.817.939.630.944.0
 - Renal insufficiency14.39.2  30.125.3
 - Stroke / transient ischemic attack15.218.96.414.0 12.5
 - Chronic lung disease11.33.58.39.531.420.1
 - Previous heart failure47.829.664.136.175.670.9
Medications at discharge
 - ACE inhibitor29.517.951.070–7583.177.0
 - Angiotensin receptor blocker39.739.426.9
 - Beta blocker49.958.678.86780.172.6
 - Aldosterone antagonist44.953.159.440–5032.853.9
 - Diuretic 68.181.5 87.283.9
  1. SD standard deviation, BMI body mass index, NYHA New York heart association functional class, SBP systolic blood pressure, DBP diastolic blood pressure, EF ejection fraction, ACE angiotensin converting enzyme